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Abstract: The existence of a mitochondrial interactosome (MI) has been currently well 
established in mammalian cells but the exact composition of this super-complex is not 
precisely known, and its organization seems to be different from that in yeast. One major 
difference  is  the  absence  of  mitochondrial  creatine  kinase  (MtCK)  in  yeast,  unlike  that 
described in the organization model of MI, especially in cardiac, skeletal muscle and brain 
cells. The aim of this review is to provide a detailed description of different partner proteins 
involved in the synergistic ADP/ATP transport across the mitochondrial membranes in the 
yeast Saccharomyces cerevisiae and to propose a new mitochondrial interactosome model. 
The ADP/ATP (Aacp) and inorganic phosphate (PiC) carriers as well as the VDAC (or 
mitochondrial  porin)  catalyze  the  import  and  export  of  ADP,  ATP  and  Pi  across  the 
mitochondrial membranes. Aacp and PiC, which appear to be associated with the ATP 
synthase,  consist  of  two  nanomotors  (F0,  F1)  under  specific  conditions  and  form  ATP 
synthasome. Identification and characterization of such a complex were described for the 
first time by Pedersen and co-workers in 2003. 
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1. Introduction  
An essential step in the determination of structure-function relationships at a molecular level is  
to  investigate  the  intrinsic  properties  of  isolated  proteins,  via  molecular  biology,  biochemical  and 
structural approaches [1–3]. However, it is also necessary to study protein function in an integrated 
system  in  order  to  understand  the  phenomena  in  cellular  and  physiological  contexts.  Energy 
metabolism is an example in bioenergetics, which operates as an integrated network of molecular 
interactions, where the spatial and temporal organization of each of these cellular compounds is crucial. 
It is especially important, if one takes into account the high degree of complexity of eukaryotic cells and 
the diversity and abundance of proteins. In addition, all membranes, which macrocompartmentalize the 
cytosol [4] and cytoskeletal network [5], are barriers to the metabolite diffusion as well as the density 
of the cytoplasmic macromolecular complexes [6]. Indeed, the concentration of macromolecules in  
the bacterial cytoplasm is about 300–400 mg/mL [7] representing 30% of the total volume. In the case 
of  the mitochondrial matrix of eukaryotic cells, it amounts to  60% [8]. This  organization and  the 
intracellular  macromolecular  crowding  result  in  restriction  of  metabolite  diffusion  [9],  creating 
confined spaces named microcompartments isolated from the rest of cellular processes [10]. This results 
in an increase of the local protein concentrations altering the equilibrium constants by promoting the 
association of the macromolecules with each other [11] to form  multi-protein [12] or protein-DNA 
complexes [13]. Enzymatic reactions with small molecules are favored [14]. Overall this plays a key 
role  in  protein  folding  [15,16]  and  conformational  changes [17,18].  It  is  easy  to  understand  the 
fundamental role of the intracellular complex environment on the major cellular functions and the 
stakes of a holistic approach with molecular biology systems. The microcompartments, involving the 
concepts of multi-enzyme complexes and metabolic channeling, are the basis of the organization and 
regulation  of  cellular  energy  metabolism  [19–21].  Indeed,  the  transfer  of  substrates  is  carried  out 
through  interconnected  metabolic  pathways,  either  between  two  enzymes  via  random  diffusion 
according to the Einstein-Smoluchowski equation [22] or by a direct transfer [23,24]. These functional 
couplings allow the accumulation of products and reaction intermediates in a confined space. The 
importance of such phenomena lies partly in the fact that physically associated enzymes or transient 
multi-enzyme complexes have the potential to exhibit unique catalytic properties in contrast to isolated 
enzymes [25,26]. Compartmentalization may include both metabolites and enzymes.  The enzymes 
catalyzing  sequential  reactions  in  given  metabolic  pathways  have  been  proposed  to  be  highly 
organized in supra-molecular complexes named ―metabolon‖ by Paul Srere [27–29]. They are involved 
in signaling cascades or metabolic pathways such as glycolysis [30–34], of which the enzymes can be 
linked to the cytoskeleton [35–39], tricarboxylic acid cycle [40], lipid and amino acid metabolisms 
[41,42], or protein biosynthesis [43]. The most representative example of functional coupling  was 
described  for  the  first  time  by  Pedersen  et  al.,  in  the  case  of  myocardial  cells  in  which  the 
mitochondrial  creatine  kinase  (MtCK)  located  in  the  intermembrane  space  is  coupled  to  the  ATP 
synthasome  [44].  The  ATP  synthasome  corresponds  to  a  super-complex  located  in  the  inner 
mitochondrial membrane and comprising the ADP/ATP carrier, the inorganic phosphate (Pi) carrier 
and  the  F1F0-ATP  synthase.  It  is  driven  by  the  proton  electrochemical  gradient  [45,46],  which  is 
generated  by  the  respiratory  chain  to  catalyze  ATP  synthesis  from  ADP  and  Pi.  This  biological 
phenomenon achieves a functional coupling, which avoids an entropy increase. It is reminiscent of the Int. J. Mol. Sci. 2012, 13                   
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thermodynamic properties associated with a philosophical concept, which was subject to much debate 
in the history of physical science, because it contradicts the second law of thermodynamics, namely 
Maxwell’s demon theory [47]. One of the clearest pieces of evidence for such a functional coupling 
comes from the measurement of the apparent KM of the ADP/ATP carrier for ADP, which provides 
information about the availability of ADP for oxidative phosphorylation (OxPhos). Indeed, it was noted 
that  the  value  KM  measured  with  isolated  mitochondria  is  about  10  μM,  depending  on  organisms. 
However, in situ, this value is 20-times higher in myocardial fibres [48], reflecting mainly a slower ADP 
diffusion. The addition of creatine (Cr) reduces the KM value, highlighting the role of the functional 
coupling of creatine kinase (CK) and the ADP/ATP carrier in energy metabolism. 
The aim of this review is to provide a detailed description of the different partners involved in 
synergistic  ADP/ATP  transport  across  the  mitochondrial  membranes  in  the  yeast  
Saccharomyces cerevisiae and to describe on the basis of detailed literature analyses what could be a 
mitochondrial interactosome. 
2. The Different Proteins Involved in the Mitochondrial Membrane Transport of  
Adenine Nucleotides 
2.1. The ADP/ATP Carrier 
2.1.1. Overview 
A member of the Mitochondrial Carrier Family (MCF), the mitochondrial ADP/ATP carrier (Aacp) 
fulfills the cellular energetic needs by exchanging the neo-synthesized matrix ATP for the cytosolic 
ADP. In 1965, E. Pffaf discovered a specific exchange of adenine nucleotides through the membranes 
of  mitochondria  isolated  from  rat  liver  and  demonstrated  the  existence  of  a  specific  carrier  [49].  
Later, other groups showed that this carrier was a protein [50]. The name of mitochondrial ADP/ATP 
carrier was then proposed [51]. This protein plays a very important physiological role in the renewal of 
cellular energy. Indeed, a human adult renews his own weight of ATP per day and a large proportion 
of it passes through the ADP/ATP carrier. In spite of this, Aacp has a low transport activity, i.e., about 
1000 to 2000 min
−1 at 20 ° C in mitochondria isolated from rat heart [52,53]. This low rate of transport 
is  physiologically  balanced  by  the  abundance  of  the  protein  in  the  mitochondrial  membranes  and  
its functional coupling. In certain tissues, Aacp may represent almost 10% of the proteins of the inner 
mitochondrial membrane. Under physiological conditions, one cytosolic ADP
3− molecule is exchanged 
against one matrix ATP
4− molecule, both in the form of free nucleotides each carrying 3 or 4 negative 
charges,  respectively.  Therefore,  this  exchange  is  electrogenic  and  its  direction  is  driven  by  the 
membrane electrochemical potential created by the respiratory chain [54,55]. In the absence of this 
potential, the ADP/ATP carrier exchanges either ADP
3− or ATP
4− against one or another according to 
the concentration gradient [56]. The discovery and characterization of Aacp are related to the finding 
of specific inhibitors belonging to two families: atractyloside (ATR and its in vivo biological precursor, 
the carboxyatractyloside (CATR)) and bongkrekic acid (BA). It has been established that CATR and 
BA can recognize distinct pre-existing carrier conformations, commonly known in the literature as 
―CATR conformer‖ and ―BA conformer‖. Both conformations are stabilized by inhibitor binding and 
represent extreme states adopted by the carrier during the ADP and ATP translocation process. This Int. J. Mol. Sci. 2012, 13                   
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transport mechanism has been extensively studied thanks to CATR and BA (Figure 1). The structure of 
isoform 1, of the bovine ADP/ATP carrier (Ant1p) in complex with CATR, was solved in 2003 at high 
resolution [57]. It is characterized by a wide cavity open to the intermembrane space, which is probably 
involved in the transport mechanism. CATR is located deep inside and interacts with residues R79, N87, 
K91, R187, R234 and D231. On the assumption that CATR and ADP binding sites overlap, at least 
partially, some interesting predictions were made [58]. The Uncoupling Protein (UCP2) structure, a 
MCF member, was recently solved and both proteins exhibit similar organization: six transmembrane 
segments delineating the cavity, open towards the cytosol and three large matrix loops [59]. However, 
UCP2 is less tightly closed on the matrix side than the ADP/ATP carrier. Despite this outstanding 
progress,  biochemical  data  currently  available  do  not  give  insights  into  the  precise  molecular 
mechanism of ADP and ATP translocation across the inner mitochondrial membrane. 
Figure 1. Conformational states adopted by the ADP/ATP carrier during the nucleotides 
transport. carboxyatractyloside (CATR) and bongkrekic acid (BA) inhibit the transition by 
locking the carrier in stable complexes. 
 
2.1.2. Oligomeric State of the ADP/ATP Carrier 
In 1975, the first data on the possible multimerization of the ADP/ATP carrier was published [60]. 
Analyses of the CATR/protein stoichiometry were in favor of one mole of inhibitor bound to two 
moles of the ADP/ATP carrier, suggesting a dimeric organization of the carrier. These results were 
later confirmed by other physico-chemical and biophysical analyses. 
Analytical centrifugation and small-angle scattering experiments suggested a dimeric organization of 
the protein in detergent micelles [61–63]. In addition, experimental evidence for a dimeric organization 
of other MCF members, such as the oxaloglutarate, citrate, or Pi carriers, support the hypothesis of an 
oligomerization of the mitochondrial carriers [64,65]. A tetrameric functional unit of Aacp was also 
suggested because two nucleotide binding sites on each side of the carrier and of different affinities were 
characterized for one transport unit [66,67]. However, recent findings questioned the existence of an 
oligomeric state of MCF members. The high-resolution structure obtained for the CATR-Ant1p complex 
shows a single monomer bound to a molecule of CATR. Later on the authors obtained another structure 
where a single monomer is in contact with another monomer through cardiolipins [68]. However, the 
crystallographic dimer appears artefactual and is contradictory to previously published data because it 
contains one  molecule of CATR per monomer. Neverless, recent experiments based on analytical 
centrifugation with improved in system analyses and data processing, confirm the results published  
in the early 80’s. These data also suggest that if Ant1p forms predominantly monomeric complexes Int. J. Mol. Sci. 2012, 13                   
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with CATR in Triton X-100 solution, it can also form multimeric complexes [69]. A  monomeric 
organization  of  the  yeast  Aacp  was  recently  claimed  through  the  use  of  various  biochemical  or 
biophysical approaches [70–72]. 
2.1.3. The ADP/ATP Carrier of S. Cerevisiae 
Studies of the ADP/ATP transport were conducted for many years with S. cerevisiae thanks to the  
ease of genetic engineering of this organism [73]. S. cerevisiae has three isoforms named Aac1p, Aac2p, 
and Aac3p, with different physiological characteristics. Isoform 1 is encoded by the AAC1 gene on 
chromosome XIII in yeast. Aac1p is expressed weakly and constitutively under aerobic conditions and 
repressed  in  the  presence  of  oxygen  [74].  The  second  isoform  is  encoded  by  the  AAC2  gene  on 
chromosome II and is highly expressed under aerobic conditions in the presence of a non-fermentable 
carbon source such as lactate [75]. Aac2p is necessary for yeast growth on a non-fermentable carbon 
source  and  therefore  represents  the  homologue  of  the  human  Ant1p,  sharing  approximately  50%  
of sequence identity [76] (Figure 2). Because of its high expression and its involvement in energy 
production during respiration, the second ADP/ATP carrier isoform of S. cerevisiae has been the most 
studied. The third isoform is encoded by the AAC3 gene whose expression is repressed in the presence 
of oxygen [77,78]. The three genes encode transporters of 309, 318 and 307 amino acids, respectively. 
When overexpressed, AAC1 and AAC3 can complement an aac null strain. 
Figure 2. Primary sequence alignment of bovine ADP/ATP carrier (Ant1p) and ADP/ATP 
carrier (Aac2p). Sequence alignment was performed with the Needle program. The bars 
show the identical amino acids and the two points the similar residue. Numbering refers to 
the Aac2p sequence. Both sequences are 49.5% identical. 
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2.1.4. Human Pathophysiological Aspects 
Four human genes named ANC1/ANT1, ANC2/ANT3, ANC3/ANT2 and ANC4/ANT4 encode for the 
ADP/ATP carrier in different tissues. Isoform 1 is expressed in the heart and skeletal muscles, brain 
and organs with low mitotic regeneration. Isoform 2 is found weakly throughout the human body. The 
third isoform is highly expressed in growing cells, with high energy needs, such as the kidneys, liver, 
spleen but also in cancer cells [79,80]. Finally, the fourth isoform has been identified from a collection 
of expressed sequence tags and this transcript was localized in the testis, liver and brain [81]. The 
direct  involvement  of  human  ADP/ATP  carrier  mutants  was  described  in  five  cases  of 
ophthalmoplegia and one case of cardiomyopathy [82]. 
2.2. The Inorganic Phosphate Carrier—PiC 
The mitochondrial phosphate carrier (or Phosphate Transport Protein or p32) catalyzes the transport 
of Pi into the mitochondrial matrix where it is mainly used for OxPhos [83–86] and especially for the 
ATP biosynthesis. Like the ADP/ATP carrier, this transporter is essential for cell development of 
strictly aerobic organisms. 
2.2.1. Discovery and Biochemical Properties of PiC 
The bovine PiC carrier and the associated gene (PIC) were discovered in the mid-80’s [87,88].  
The  PIC  gene  was  subsequently  sequenced,  cloned  and  studied  in  the  yeast  S.  cerevisiae  [89].  A  
bi-functionality was described and was then the matter of a long controversial debate. Its secondary 
hypothetical role as an import receptor for nuclear-encoded preproteins into mitochondria was disproved 
by Zara’s group who stated the alone function of PiC in the translocation of Pi [90]. This carrier is a 
MCF member, with six transmembrane segments [91,92], but remains poorly characterized compared  
to Aacp. 
2.2.2. Transport Mechanism of Mitochondrial PiC 
The Pi carrier catalyzes the electroneutral transport of phosphate through the inner membrane from 
the intermembrane space to the mitochondrial matrix but the involved mechanisms are poorly understood. 
Nevertheless,  a  passive  mode  of  transport  using  the  proton  gradient  driven  by  membrane  potential  
(ΔΨ) was proposed. The PiC would work as a Pi/H
+ symporter [93,94] or alternatively as a Pi/OH
− 
antiporter [95]. It was also suggested that the Pi can be transported only as monocharged ion [96]. 
With regards to the mechanism of transport, some experiments show that PiC of S. cerevisiae can 
switch to a uniport mode after being modified at cysteine 28 in the presence of mercury (HgCl2) [97]. 
Finally, PiC is inhibited by fatty acids, particularly the 12-(4-azido-2-nitrophenylamino) dodecanoic acid 
(AzDA) [98] and can be photolabeled by fatty acid derivatives bearing an azido-nitrophenyl group. Thus, 
the authors proposed that this carrier may also be involved in the metabolism of fatty acids. 
Biochemical  studies  of  the  yeast  Pi  carrier  were  carried  out  after  exogenous  expression  in  the  
form of inclusion bodies in Escherichia coli [99]. Functional studies of the yeast PiC showed that  
N-ethylmaleimide (NEM) could specifically target cysteine 28 of the carrier with the stoichiometry of 
one NEM per PiC subunit to inhibit the transport of Pi. Studies of cysteine mutants of the yeast Pi Int. J. Mol. Sci. 2012, 13                   
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carrier expressed from inclusion bodies were subsequently performed [97]. The cysteines at position 
28, 134 and 300 were replaced one by one with serines. The results initially showed that cysteine 300, 
near the C-terminus and cysteine 134, located in the third transmembrane segment, are accessible  
to the hydrophilic reagent butyl-SH, in contrast to cysteine 28 localized in the first transmembrane 
segment. This binding to the reactive cysteine 134 results in complete inhibition of the transport. The 
reversible conversion capacity of PiC to form a uniport mode of transport to an antiport appears to be 
dependent only on cysteine 28. The PiC of S. cerevisiae expressed in inclusion bodies in E. coli may 
be  partially  resolubilized  in  the  presence  of  sarkosyl  detergent  and  is  monomeric  or  unstructured.  
After  exchanging  sarkosyl  with  a  polyoxyethylene  and  dialysis,  PiC  is  organized  in  stable  and 
functional dimers [100]. Although it is accepted that Aacp has common features with PiC, there is 
currently no biochemical evidence for a monomeric organization of PiC unlike with Aacp [101]. Mayr 
and co-workers [102] described patients with mitochondrial phosphate carrier deficiency. A young 
adult presented cyanosis and muscular hypotonia. A hypertrophic cardiomyopathy was detected with 
low  cardiac  output  and  elevated  levels  of  lactate  in  plasma.  Severe  muscular  hypotonia  was 
also observed. 
2.3. The Mitochondrial Porin 
In contrast to the high selectivity of the inner membrane, due to the presence of specific carriers as 
Aacp or PiC, the outer membrane is more permeable and plays a key role as a molecular filter, retaining 
molecules greater than 3000–5000 Da [103]. This controlled diffusion of metabolites occurs through 
transmembrane channels present in large amounts in all eukaryotes: the mitochondrial porins. Thus, in 
the case of the yeast S. cerevisiae, analyses carried out after purification of the porin isoform 1 (denoted 
Por1p, the most abundant isoform) show that this protein represents at least 10% of the total proteins of 
the mitochondrial outer membrane [104] and up to 50% in Neuraspora crassa [105]. 
2.3.1. Identification and Physiological Characteristics of Porin 
The first studies on the biochemical composition of outer membrane proteins in different eukaryotes 
confirmed a major protein with a molecular mass of about 30 kDa with an unknown function [105]. In 
1976, it was identified in the unicellular organism Paramecium aurelia. After that, it was reconstituted 
in an artificial membrane, and its electrophysiological characteristics were described [106]. It was then 
named VDAC for ―Voltage-Dependent Anion Channel‖. Subsequently, this porin was identified in rat, 
beef, S. cerevisiae, N. crassa [107] and in other eukaryotic organisms, with highly conserved biochemical 
and biophysical properties [108]. 
The electrophysiological experiments conducted on the reconstituted porin in liposomes or planar 
lipid bilayers show that the VDAC controls the metabolites flow through changes in the frequency  
of channel opening following membrane potential [109]. Thus, there is a condition called ―open‖ state, 
where porin is slightly selective to anions. It is characterized by high permeability and the presence of 
large water-filled pores (2–3-nm diameter), observed by transmission electron microscopy [110]. 
Conversely, when the membrane potential difference is greater than 30 mV, it is possible to distinguish 
another state called ―closed‖, in which the permeability is reduced and does not allow the transport of 
anions such as ADP
3− or ATP
4−. It was shown in vitro that the opening of the channel is regulated by Int. J. Mol. Sci. 2012, 13                   
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various molecules, such as glutamate and NADH [111]. Although these electrophysiological experiments 
afford a convenient test for the mitochondrial porin functionality revealing molecules that influence the 
opening or closing of the channel, it is important to remember that, in vivo, the outer mitochondrial 
membrane is not subjected to a membrane potential due to its permeable nature, although some works 
attest to the contrary [112–114]. Depending on the organism, there may be multiple isoforms of VDAC 
and it is interesting to note that the more complex the organism, the higher the number of isoforms. 
Thus, there is only one isoform in N. crassa while in mice and humans three isoforms exist. In the 
yeast S. cerevisiae, there are two isoforms of porin. The most abundant, and therefore the most studied 
one, is the isoform 1 (denoted Por1p) which is encoded by the nuclear gene POR1 [104]. Isoform 2 
(denoted Por2p) is encoded by the gene POR2 and is 50% identical to Por1p [115]. In contrast to the 
latter isoform, Por2p is weakly expressed in mitochondria, regardless of the culture conditions, and 
exhibits a low permeability to metabolites [116]. Contrary, to Aacp and PiC, VDAC is not essential for 
the yeast growth on a non-fermentable carbon source. It was assumed that the facilitated diffusion of 
small  molecules  across  the  mitochondrial  outer  membrane  is  mediated  exclusively  by  the  porin. 
However, the viability of the Δpor mutant suggests the existence of another pathway for metabolite 
exchange between mitochondria and cytosol [117,118]. 
2.3.2. High-Resolution 3D Structures of Porin 
By examination of its 3D structure, porin can be divided into two parts. The core of the protein 
corresponds to the relatively mobile transmembrane channel composed of 19 antiparallel β-sheets. The 
―soluble‖ N-terminal extension is twenty amino acids long, folded into an α-helix and connected to the 
 barrel by a hinge peptide. The high-resolution 3D structures of human and murine VDAC1 porins 
(hVDAC1 and mVDAC1) were recently determined (Figure 3) [119–121]. Each of them was obtained 
using a similar approach based on the exogenous expression of VDAC1 within inclusion bodies in the 
bacteria E. coli. This requires refolding of VDAC in the presence of detergent. The aim was to obtain 
large amounts of protein, which is a preliminary requirement for X-ray crystallography and NMR 
spectroscopy  (Nuclear  Magnetic  Resonance).  Hiller  and  colleagues  were  the  first  to  elucidate  the 
structure of the porin hVDAC1 at high resolution, in the detergent LDAO (Lauryldimethylamine-oxide),  
by NMR spectroscopy [120]. Bayrhuber and colleagues used an approach combining NMR spectroscopy 
and X-ray crystallography to obtain the porin structure in Cymal-5. However, it was resolved at a lower 
resolution (4 Å) [119]. Finally, Abramson’s team determined the crystal structure of the murine VDAC1 
solubilized  in  the  presence  of  the  lipid  (1,2-dimyristoyl-sn-glycero-3-phosphocholine)  and  the 
detergent CHAPSO and resolved it at high resolution (2.3 Å) [121]. It is interesting to note that the 
three final structures are relatively similar. Indeed, the human and murine porins are organized in a 
barrel consisting of 19 stranded antiparallel β-sheets with the N-and C-termini pointing towards the 
cytosol,  classifying  the  mitochondrial  porin  in  a  new  family  of  porins  [120].  One  of  the  major 
differences between these structures is the N-terminal α-helix, which was described in two of the three 
structures solved. Its orientation within the channel is a matter of debate (Figure 3). The reason for this 
difference  is  unclear  but  may  potentially  be  related  to  the  experimental  conditions:  histidine  tag 
position, type of detergent used, and pH of refolding. Nevertheless, these results are consistent with the 
idea that the N-terminal end may be involved in the mechanism of opening and closing of the pore via Int. J. Mol. Sci. 2012, 13                   
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its motion. Indeed, in the structure described by Hiller, the N-terminal segment divides the lumen into 
two parts [120]. It was then suggested that it corresponds to a closed state since the pore diameter is 
reduced compared to the other structures of VDAC. In contrast, in the crystal structures of mVDAC1 
and hVDAC1 porins, the N-terminus is located horizontally against the inner wall of the barrel and is 
parallel to the membrane plane [119,121]. This location has two consequences: (i) the pore diameter 
appears larger, (ii) the electrostatic distribution is changed in favor of a global positive charge. It  
was therefore suggested that these structures probably correspond to states of the anion-selective pore 
open towards the cytosolic side. The importance of the N-terminal domain in the mechanism of pore 
opening and closing is still under debate. However, complementation studies were undertaken with 
human cells of which the endogenous VDAC was knocked down by siRNA. A mutant mVDAC porin, 
lacking its first 26 amino acids, was expressed in these cells which presented the same characteristics 
as wild type cells [122]. This surprising result suggests that the N-terminus is not essential for the main 
VDAC function, which is transporting small solutes. However, the authors showed that the N-terminal 
domain of VDAC is an essential mediator in apoptosis. Indeed, this domain is involved in the release 
of cytochrome c in the cytosol and in the recognition of anti-apoptotic proteins such as hexokinase 
and  Bcl2. 
Although, some aspects are still controversial, the 3D structures of VDAC recently obtained are a 
major asset in understanding the molecular mechanisms involved in the transport of small metabolites 
such as ADP, ATP and Pi through the outer membrane of mitochondria. This mechanism seems now 
to be generating major interest. However, since their discovery, these NMR and X-Ray determined  
3D structures are still the subject of relentless and heated debate, which is not mentioned in this review. 
In  fact,  disagreement  arises  when  it  comes  to  determine  the  exact  topology  of  VDAC  in  the 
membranes as well as the number and orientation of the β-sheets that form the barrel. According to 
Colombini, these 3D structures are not consistent with previous functional data. This author suggests 
that  none  of  them  correspond  to  the  native  structure.  Instead,  he  proposes  a  functionally-derived 
structure of the pore composed of one α-helix and 13 β strands tilted at a 46°  angle with an internal 
diameter of 2.5-nm [123]. The gating mechanism of the voltage-dependent anion channel implies the 
existence of one or more voltage-sensor domains. Indeed, Colombini proposes a model of a voltage 
gating process involving a mobile positively charged voltage-sensor domain, whose position is driven by 
the  membrane  potential.  This  large  conformational  change  was  deduced  from  porin  properties  of 
conductance, pore size, selectivity and pore volume [123]. Thus getting a good fit between functional 
and structural data remains very challenging for the porin but also for numerous other proteins. 
2.3.3. Selectivity of the Pore 
With regard to the transport of metabolites, VDAC has long been considered as an ordinary molecular 
filter whose selectivity cannot be reduced to its pore diameter. On this principle, all molecules with a 
steric bulk adapted to the size of the pore could potentially cross through. However, today this definition 
seems outdated. Indeed many studies suggest that the mitochondrial porin has some selectivity since 
several binding sites and protein partners have been identified. Thus the protein seems to have a much 
larger dimension than previously thought, due to its involvement in major cellular functions (channels 
energy, cell death, etc.). Int. J. Mol. Sci. 2012, 13                   
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Figure  3. Structure of mitochondrial porins (a) Isoform 1 of human porin obtained by 
NMR spectroscopy [120] (1) and by an approach combining both NMR spectroscopy and 
X-ray crystallography [119] (2); (b) High-resolution structure of an isoform of the murine 
Voltage-Dependent Anion Channel (VDAC1) solved by X-ray crystallography [121]. All 
these  structures  exhibit  a  channel  formed  by  19  stranded  antiparallel  β-sheets  in  the 
transmembrane core protein. The N-and C-terminal ends are oriented towards the cytosol. 
These structures classify protein VDAC in a new family of porins. The N-terminus is an 
organized structure (α-helix) or not, whose orientation differs from one model to another.  
 Int. J. Mol. Sci. 2012, 13                   
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2.3.3.1. Nucleotide Binding and Derived Molecules  
It was previously suggested that the VDAC porin is regulated by adenine nucleotides and their 
derived molecules [124–126]. In the case of N. crassa porin, it was shown that NAD(P)H, ATP and 
ADP  regulate  the  diameter  of  the  pore  and  the  existence  of  ATP  binding  sites  (NBS  noted  for 
―Nucleotide-Binding Sites‖) has been proposed [127–130]. 
The presence of NBS in mammalian VDAC porins was confirmed by their binding to ATP agarose 
columns  [124].  In  addition,  interaction  between  ATP  and  porin  was  demonstrated  by  binding 
experiments with radiolabeled ATP (noted [
32P]-ATP) [124]. More recently, Yehezkel and colleagues 
demonstrated ATP binding at low and high affinity sites of mVDAC1 using a photoactivable analogue 
of ATP (benzoyl-benzoyl-ATP noted [α-
32P]-BzATP) [131]. 
MALDI-ToF-MS analyses of porin, labeled with [α-32P]-BzATP, confirmed the binding of two 
molecules  of  BzATP  per  porin  molecule.  The  sites  are  located  in  the  C-terminal  (271–283)  and  
N-terminal (19–25) regions of the porin [131]. Studies by site-directed mutagenesis supplemented 
these results by showing the importance of lysine 20 in the binding of mVDAC1 to ATP [132]. 
2.3.3.2. Binding of Ca
2+ 
Ca
2+ plays a major role in the cell by creating a link between the mitochondria and the cytosol. In 
point of fact, calcium is primarily an intracellular messenger in signal transduction [133–135]. The 
intramitochondrial Ca
2+ concentration modulates the activity of critical enzymes of the Krebs cycle, 
oxidation of fatty acids, catabolism of amino acids, ATP synthase and Aacp. 
In the mammalian mitochondria, elevated matrix Ca
2+ concentrations (over 1 to 3 µ M) induce an 
increase  in  the  permeability  of  the  inner  membrane  caused  by  the  opening  of  a  nonspecific  pore 
(―Permeability Transition Pore‖ or PTP) [136,137]. It was shown that the hVDAC1 is permeable to 
Ca
2+ and exhibits binding sites, which control its activity [138]. They were identified through the use 
of a photoactivatable reagent, azido ruthenium (AzRu), which is able to interact specifically with Ca
2+ 
binding  proteins  and  accordingly  significantly  inhibits  activity.  MALDI-ToF-MS  analyses  of  
AzRu-labeled mVDAC1 reveal the presence of two Ca
2+ binding sites corresponding to residues E72 
and E202 [139]. 
2.3.3.3. Potential Partners of the Porin 
Table 1 summarizes the main protein partners interacting with the VDAC and involved in different 
cellular  functions.  They  are  mainly  hexokinase  [140–143],  Aacp  [144–146],  MtCK  [147–150],  
pro-apoptotic proteins belonging to the Bcl2 family [151–154], tubulin (described as factor X) [155–158] 
and IP3 receptor [159]. 
In S. cerevisiae, the interaction of tubulin with VDAC is not obvious since it is known that the 
mitochondrial dynamics are driven primarily by interactions with the actin cytoskeleton [160]. The 
interaction domains characterized or hypothesized are presented in Table 1. Int. J. Mol. Sci. 2012, 13                   
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Table 1. The potential partners of the mitochondrial porin. 
Protein 
partners 
Interaction partners 
domain 
Mediators 
Interaction  
VDAC * domain 
Roles  Functions 
References 
activators 
(+) 
inhibitors 
(−) 
Hexokinase I 
and II (HK I 
and HK II) 
N-terminal hydrophobic  
α-helical 
(MIASHLLAYFFTELM) 
Mg
2+, 
Residues 
E188 and 
E202 of 
VDAC 
Glucose-6-
phosphate 
(G6P) 
and 
DCCD * 
Amino 
acids 
Location 
in the 
structure 
PTP * 
Mitochondrial 
apoptosis 
E72 
 sheet 
n° 4 
[140–142] 
E65 
Cytosolic 
loop n° 2 
[143]  D77 
Matrix 
loop n° 2 
K73 
 sheet 
n° 4 
Aacp *  Cardiolipin-induced  [144–146] 
MtCK *  Cardiolipin-induced  [147–150] 
Bcl2 family 
proteins 
H5 and H6 transmembrane 
helix 
-  -  PTP 
Mitochondrial 
apoptosis 
[151–154] 
Tubulin 
Tubulin 
anionic C-terminal tail 
(CTT) peptides 
-  VDAC lumen  regulation 
Mitochondrial 
respiration 
[155–158] 
Inositol 1,4,5-
triphosphate 
receptor 
(IP3R) 
N-terminal domain  Chaperone grp75  - 
Scaffolding 
the ER *-
mitochondria 
contacts 
Ca
2+ uptake 
into 
mitochondria 
[159] 
*  VDAC:  Voltage-Dependent  Anion  Channel;  DCCD:  N,  N-dicyclohexylcarbodiimide;  PTP:  Permeability 
Transition Pore; Aacp: ADP/ATP carrier; MtCK: Mitochondrial Creatine Kinase; ER: Endoplasmic Reticulum. 
2.3.4. Supra-Molecular Organization of Porin in the Membrane 
The oligomeric organization of porin is also discussed. Though some studies concluded that VDAC 
exists as a functional monomer, which was recently crystallized [121], other data in particular blue 
native PAGE analysis claim that structures of rat and human porins in the membrane correspond to 
dimeric,  trimeric,  tetrameric  and  hexameric  architecture  [161–167].  However,  the  reasons  for  an 
oligomerization  of  porin  are  not  completely  understood,  given  that  the  channel  through  which 
metabolites pass occupies the center of the barrel and the formation of an oligomer does not appear  
as necessary for the pore to operate. It was therefore proposed that the supra-molecular organization  
of porin has a role in stabilizing the protein. This could be also true for the bacterial porins [168].  
A recent paper describes the mVDAC1 porin in a dimeric architecture where both monomers are 
oriented in the opposite direction [121]. The hexamer arrangement of porin dimers oriented head to tail 
in the crystals could possibly mimic the native organization observed in electron diffraction studies 
[161] and more recently in AFM (Atomic Force Microscopy) experiments with the mitochondrial outer 
membranes [167]. Int. J. Mol. Sci. 2012, 13                   
 
 
1870 
2.3.5. Role of Lipids in Porin Activities 
Sterols are present in large quantities in the mitochondrial outer membrane, with five cholesterol 
molecules per monomer of porin in bovine mitochondria [169]. In the case of N. crassa [170,171] and 
S. cerevisiae [172], large amounts of ergosterol were detected in preparations of porin. The importance 
of  sterols  for  the  VDAC  function  was  shown  in  vitro  [173].  Indeed,  Dictyostelium  discoideum, 
Paramecium  and  rat  porins,  once  delipidated,  are  unable  to  form  functional  channels  in  artificial 
membranes. However, simple pre-incubation of these proteins in the presence of sterols and detergent 
allows them to regain the ability to transport. This suggests that sterols are essential to the proper 
functioning of porin in  the  mitochondrial outer  membrane.  However,  these  results can  be  viewed  
with caution since, in the case of the mammalian ADP/ATP carrier reconstituted into liposomes, the 
nucleotide exchange activity is stimulated in the presence of cholesterol while the same sterols are 
absent from the inner mitochondrial membrane [174]. The effect of sterols on the function of these two 
proteins could be indirect, and caused by the change in composition, and thus of the physical state, of 
the artificial membrane used for reconstitution, and not by a specific interaction between the in vivo 
sterols and the membrane protein of interest. Other lipids seem to play a role in voltage gating of the 
pore, such as non-lamellar lipids of the mitochondrial outer membrane [175]. 
3. Mitochondrial Interactosome Model  
Mitochondrion  plays  a  key  role  in  cellular  functions.  Indeed,  it  is  involved  in  apoptosis, 
thermogenesis, calcium homeostasis, and in many anabolic pathways such as heme synthesis, protein 
in  iron-sulfur  clusters,  nucleotides  or  steroids.  Above  all  it  plays  a  fundamental  role  in  oxidative 
catabolism leading to the production of a usable form of energy, ATP. ATP synthesis is not the only 
process driven by the electrochemical proton gradient. Indeed, in mitochondria, many small charged 
molecules such as ADP and Pi are transported into the matrix from the cytosol, while others, such as 
ATP, must be transported in the opposite direction (Figure 4). Membrane proteins that realize the 
transport of these molecules can couple their transition from the inner membrane to the mitochondrial 
matrix with the energetically favorable flow of protons. For example, Pi is co-transported with a proton 
by PiC from the intermembrane space into the matrix. In contrast, ADP is transported against ATP by 
Aacp. As the ATP molecule has an additional negative charge compared with ADP, each nucleotide 
exchange is accompanied by the movement of a negative charge from the inside to the outside of the 
mitochondrial matrix. This ADP/ATP antiport is facilitated by the potential difference between both 
sides of the inner membrane. Finally, it has been suggested that passaging of adenine nucleotides and 
also Pi across the mitochondrial outer membrane is mainly carried out by the VDAC. 
The biochemical properties of the main actors of this transport machinery, Aacp, PiC and Por1p 
have been previously described. It is important to note that the model proposed in Figure 4 applies 
only to yeast, which lacks MtCK (www.yeastgenome.org/).  Int. J. Mol. Sci. 2012, 13                   
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Figure 4. Machinery model of active transport driven by the electrochemical gradient of 
protons across the mitochondrial membranes. (a) The inorganic phosphate (Pi) and ADP
3− 
are imported into the matrix via two carriers: Aac2p and PiC while the matrix ATP
4− is 
consumed  by  the  ATP  synthase,  shown  in  its  monomeric  form.  The  charge  of  each 
transported molecule is indicated. The membrane potential is negative in the matrix. The 
outer membrane ensures free passage of these compounds though the VDAC, noted Por1p; 
(b) Gel electrophoresis showing the co-purification of Aac2p, PiC and Por1p from a yeast 
mitochondria  lysate  in  n-dodecyl-β-D-maltoside/emulphogen  mix  (DDM/EM)  after 
chromatography  on  a  hydroxylapatite  column  (Coomassie  Blue  staining  of  the  
SDS-PAGE gel). 
   
(a)           (b) 
Indeed,  in  higher  organisms,  particularly  in  myocardial  cells,  the  MtCK  catalyzes  the 
transphosphorylation of creatine (Cr) to phosphocreatine (PCr) from the hydrolysis of ATP, newly 
synthesized in the mitochondrial matrix [176,177]. This enzyme forms an octamer, which is localized 
in the intermembrane space and at the level of mitochondrial cristae [178,179]. As for Aacp, it was 
shown  that  MtCK  interacts  with  membrane  receptors,  which  are  negatively  charged  phospholipid 
cardiolipin and specifically found in the inner membrane [179–181]. Other studies suggest that MtCK 
interacts with phospholipids of the outer membrane and with the VDAC porin [150]. A model in which 
MtCK is associated with VDAC and Aacp was proposed to ensure the ―channeling‖ of ATP through the 
mitochondrial membranes and, at the same time, this would contribute to the formation of mitochondrial 
contact sites [182]. The functional coupling of MtCK with ATP production has been demonstrated for 
the first time in the muscle by biochemical, kinetic, thermodynamic and radioisotopic analyses. Int. J. Mol. Sci. 2012, 13                   
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Finally, some contact sites, comprising, among others, the VDAC and the ADP/ATP carrier [183] 
would  help  in  stabilizing  the  mitochondrial  creatine  kinase  [184].  They  are  expected  to  play  an 
important role in energy metabolism and cell apoptosis [185]. This model is quite speculative as it is 
proposed  by  combining  data  from  literature  taken  independently.  However  there  is  currently  no 
evidence of direct interactions between these proteins, with the notable exception of the work done by 
Claypool and co-workers [186]. This group was interested in defining the yeast ADP/ATP carrier 
interactome. Their results demonstrate a potential interaction, mediated by the presence of cardiolipin 
(CL) associated to Aac2p, between Por1p and PiC but also with subunits of the respiratory complexes 
III  and  IV.  Nevertheless,  it  is  interesting  to  note  that  these  three  proteins  were  co-purified  by 
chromatography on a hydroxylapatite column (HTP Bio-Rad) from a lysate of yeast mitochondria in 
DDM/EM (dodecyl-β-D-maltoside/emulphogen mix) [187]. Unfortunately, there is no clear evidence 
of  stable  protein  complexes,  because  mitochondrial  dynamics  requires  some  plasticity  for 
mitochondrial organization. One hypothesis is probably that of an effect of external constraint that 
would promote the existence of this super-complex through lipids. Indeed, the interactions between 
membrane proteins and lipids are essential to many fundamental cellular processes such as respiration, 
photosynthesis,  transport  of  molecules,  signal  transduction  and  cell  motility.  Progress  in  addressing 
structural membrane proteins has revealed the presence of strongly associated lipids which are often 
located in very specific sites [57,188]. The binding of lipids gives to these proteins some structural 
stability, which can affect their folding or insertion in the cell membrane [189,190]. This model is 
probably  more  complex,  if  we  take  into  account  the  data  from  the  literature  that  demonstrate  
co-purification  of  Aac2p  with  another  component  of  the  OxPhos,  the  cytochrome  bc1-COX  
super-complex (composed of cytochrome c reductase and cytochrome c oxidase) and its association 
with the TIM23 machinery [191]. In addition, the OxPhos and the cytochrome bc1-COX are located in 
the inner membrane and the dimeric ATP synthase in cristae. A new super-complex comprising these 
proteins  was  recently  characterized  [192–194].  It  was  proposed  that  it  intervenes  directly  in  the 
architecture of mitochondria, creating contact sites at the level of cristae junctions. The formation of 
these contact sites is mediated by mitofilin (Fcj1), a hydrophobic protein located at the intermembrane 
space  and  anchored  by  its  N-terminal  domain  in  the  inner  membrane.  Fcj1  belongs  to  MINOS 
(Mitochondrial INner membrane Organization System) or MitOS (Mitochondrial-Organizing Structure) 
supercomplexes containing some other components: Aim 5, Aim 13, Aim 37 and Mio 10 (Mos1),  
Mio 27 (Mos2). As a conclusion, mitofilin plays a key role in organizing the microcompartimention in 
the intermembrane space of mitochondria and therefore in the metabolism. In addition, coupled with 
the outer membrane via the TOM complex (Tom40-Tom22), it is involved in the import of proteins. 
4. Conclusions  
In  yeast,  the  putative  mitochondrial  super-complex  is  different  from  the  one  proposed  in 
mammalian cells for various reasons. The main one is the absence of mitochondrial creatine kinase. 
Especially  in  the  myocardial  cell,  MtCK  plays  a  role  in  determining  the  functional  transport  of 
mitochondrial ATP to the rest of the cell. Its absence in yeast could be offset by a strong spatial 
promiscuity of the various partners of this protein machinery (PiC, Aac2p and Por1p), described in the 
literature  as  mitochondrial  contact  sites.  In  addition,  the  absence  of  biochemical  and  biophysical Int. J. Mol. Sci. 2012, 13                   
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evidence for the existence of physical interactions of these proteins suggests the super-complexes are 
probably glued by lipids specifically found in the mitochondrial membranes, such as ergostreol and 
cardiolipin.  This  interactosome  would  be  a  super-complex  forming  a  microcompartment  with 
particular biochemical properties and efficiently providing the ATP for the major cellular functions. 
This molecular organization will probably appear more complex since the probable oligomerization of 
mitochondrial ATP synthase dimers in yeast will be deciphered [195]. Finally, the existence of such a 
transient complex would be consistent with the dynamic nature of the mitochondrial compartment. 
Indeed, in addition to its shape variation, the mitochondrial network is constantly being reshaped by 
the  phenomena  of  apparent  balance  of  fusion  and  fission  that  determines  the  arrangement  of 
mitochondria in the cell [196]. 
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